Defining Mutual Funds, Index Funds, Exchange-Traded Funds, and Leveraged Exchange Traded Funds for New Traders
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY)
Alnylam Pharmaceuticals, Inc. is focused on the discovery, development and commercialization of RNA interference therapeutics. They currently have an approved product, ONPATTRO (patisaran), and multiple pipeline products. The company currently appears to be a good swing trade. Click to read more about my technical analysis and their siRNA technology
Seattle Genetics (NASDAQ: SGEN)
Seattle Genetics is an attractive short term swing trade. The company currently has an approved product, ADCETRIS® (brentuximab vedotin), and focuses on antibody-drug conjugate technology. Click to read more about my technical analysis and ADC technology.
Arena Pharmaceuticals (NASDAQ: ARNA)
Arena Pharmaceuticals, is a company I see value in. The company’s leading pipeline is etrasimod, in which its worldwide Phase 3 trial for the treatment of moderately to severely active ulcerative colitis is currently in the planning process. Click the title of the post to read more.
Zynerba Pharmaceuticals (NASDAQ: ZYNE)
Zynerba Pharmaceuticals, is a company I see value in. From a technical analysis standpoint, the positive uptrend is an attractive characteristic. Also, with the recent pullback, if ZYNE continues to be supported by the exponential moving average (EMA), it is currently at a “good buy” area. Click the title of the post to read more.